OCULU(R) Eyes Virtual Reality (VR) As the Next Big Frontier

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
OCULU(R) Eyes Virtual Reality (VR) As the Next Big Frontier for Pre-Roll Advertising Serving and Publisher Revenue

ORANGE COUNTY, Calif., July 9, 2014 (GLOBE NEWSWIRE) -- via PRWEB - OCULU has announced initial development of a new video player to serve pre-roll ads directly into platforms using virtual reality (VR) technology. Enhancements OCULU will make to its video streaming player allows marketers increased delivery options for pre-roll advertising messages. These advancements into VR create opportunities to directly stream micro-targeted messages. OCULU predicts that desktop and mobile device campaigns in place at this time will soon shift to include pre-roll advertising in VR. Pre-roll ads served directly into platforms using VR will ultimately garner optimum CPM.

John Cecil, OCULU CEO predicts a change for pre-roll and spot advertising. "Think about it," he says, "The ability to deliver pre-roll ads in VR will completely change the way advertisers think about commercials. Advertisers will be able to insert their video ads directly into the spawning VR platforms and devices. Pre-roll will never be the same." Cecil is excited about the new video player's ability to serve pre-roll ads directly into VR platforms, including game headsets. He expects that the OCULU® streaming platform will create an experience for viewers and advertisers never seen before in the history of marketing.

OCULU and the advertising industry see great potential in CPM lift for a pre-roll ad delivered on a VR platform to be in the range of $50 or more. Currently, ad revenue is less for pre-roll delivered via mobile devices and ranges from $15-$35 per thousand. OCULU executives expect the delivery of pre-roll ads in VR to show up quickly during online movie viewing, live events, peer-to-peer communications and gaming activities. Pre-roll ads will naturally fit into these industries in addition to others currently being identified. Cinematographers and game makers, for example, can expand views relevant to monetizing their creative works.

"Virtual reality is a new frontier," says David Winters, OCULU Chief Technology Officer. "This is not the first time we have sprung into action to tackle a new medium. We adjust our platform to target new marketplace mediums. VR will be no different because we continually enhance our video delivery system to enable compatibility on ever-evolving operating systems and platforms."

OCULU executives are highly optimistic about the endless opportunities created by the new advertising player for current and future customers worldwide. Incorporating the new pre-roll player to serve advertising media directly into virtual reality (VR) will further boost the millions of videos streamed and pre-roll ads served now every day by OCULU to online viewers throughout the world. Revenue generated by the online video platform industry is expected to top $5 billion by 2016.

ABOUT OCULU®

Oculu is a fast growing, cloud based online video platform providing video solutions and supply side monetization for both businesses and publishers. Built with DNA from the video production industry, Oculu provides video solutions with simple, do-it-yourself options and features like Video SEO, Video Email, and Video Sharing. Along with an abundant network of ad serving partners for pre-roll needs, the platform provides an easy integration when monetizing video content. Additionally, Oculu reports multiple points of data via a reporting feature that includes pre-roll metrics and information on the videos after a video plays. Oculu is fully developed, scalable and has delivered millions of video plays for over active 300 customers.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/07/prweb12005098.htm

Oculu John Cecil +1 (949) 330-6293

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 527

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 116

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 350

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 63

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 554

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 356

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 270

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 462

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 284

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Large-Cap Stocks to Watch for Future Growth Opportunities

Updated Category News Views 409

Emerging Large-Cap Stocks: Evaluating Performance Last week proved to be a robust period for several large-cap stocks, demonstrating significant gains on the market. If you're looking to expand your portfolio with top performers, it's essential to keep an eye on these standout companies. AeroVironment's Spectacular Performance AeroVironment, Inc. (NASDAQ: AVAV) saw its...

Continue Reading
Celebrating 80 Years of Unity: Manchester Congress Reimagined

Updated Category News Views 373

Celebrating the Legacy of the Manchester Congress The Pan-African Progressive Front (PPF), working hand in hand with various organizations, has embarked on an exciting journey to commemorate the 80th anniversary of the historic Manchester Congress. This momentous event, pivotal in shaping pan-African unity and liberation movements, is set to stir conversations and inspire...

Continue Reading
Stifel Optimistic on Nurix's NX-5948 Ahead of ASH Presentation

Updated Category News Views 86

Stifel's Positive Adjustment for Nurix Therapeutics Stock Stifel, a well-known financial services firm, has shown renewed confidence in Nurix Therapeutics Inc. (NASDAQ: NRIX) by increasing its price target for the company’s shares from $30 to $34 while keeping a Buy rating. This optimistic outlook reflects anticipation surrounding Nurix's ongoing drug trials,...

Continue Reading
Josh Christie Steps Up as Chief Managing Partner at Ice Miller

Updated Category News Views 266

Josh Christie Steps Up as Chief Managing Partner at Ice Miller Ice Miller is excited to share that Joshua Christie will serve as its new Chief Managing Partner starting January 1, 2026. His election reflects the firm’s trust in his leadership capabilities and vision for the future. Based in the Indianapolis office, Christie has been an integral part of Ice Miller since...

Continue Reading
IPSEN's Latest Buy-Back Initiative: Weekly Summary Insights

Updated Category News Views 156

IPSEN's Buy-Back Program Overview IPSEN has embarked on an exciting buy-back program aimed at enhancing shareholder value by strategically purchasing its own shares. This initiative is not only an investment in its financial health but also reflects the confidence IPSEN has in its future. As of Week 33, 2025, a comprehensive overview of the transactions executed...

Continue Reading